Mariner
AVXL icon

Mariner’s Anavex Life Sciences AVXL Stock Holding History

Mariner’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Buy
52,921
+14,100
+36% +$61.1K ﹤0.01% 3217
2025
Q4 		$138K Buy
38,821
+12,465
+47% +$76.4K ﹤0.01% 3267
2025
Q3 		$235K Buy
+26,356
New +$267K ﹤0.01% 3028
2024
Q2 		– Sell
-10,919
Closed -$55.6K – 3166
2024
Q1 		$55.6K Buy
+10,919
New +$61.5K ﹤0.01% 3015

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mariner's AVXL Position: Q1 2026 in Review

Mariner increased its Anavex Life Sciences (AVXL) stake by 36% in Q1 2026, buying an estimated $61.1K and bringing the position to 52,921 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

Mariner first reported a position in AVXL in Q1 2024 and has held it in 4 quarters since. The position peaked at $235K in Q3 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Mariner held 52,921 shares of Anavex Life Sciences worth $162K as of Q1 2026.
  • Mariner bought 14,100 Anavex Life Sciences shares in Q1 2026, an estimated $61.1K.
  • Anavex Life Sciences made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3217 holding.
  • Mariner first reported a position in Anavex Life Sciences in Q1 2024 and has held it in 4 quarters since.
  • Mariner's Anavex Life Sciences position peaked at $235K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.